| Literature DB >> 35323513 |
Fuhang Song1, Jiansen Hu2, Xinwan Zhang3, Wei Xu3, Jinpeng Yang3, Shaoyong Li4, Xiuli Xu3.
Abstract
Two new cyclized thiolopyrrolone derivatives, namely, thiolopyrrolone A (1) and 2,2-dioxidothiolutin (2), together with the kn own compound, thiolutin (3) were identified from a marine-derived Streptomyces sp. BTBU20218885, which was isolated from a mud sample collected from the coastal region of Xiamen, China. Their chemical structures were determined using spectroscopic data, including HRESIMS, 1D and 2D NMR techniques. 1 possessed a unique unsymmetrical sulfur-containing thiolopyrrolone structure. All the compounds were tested for bioactivities against Staphylococcus aureus, Escherichia coli, Bacille Calmette-Guérin (BCG), Mycobacterium tuberculosis, and Candida albicans. 1 displayed antibacterial activities against BCG, M. tuberculosis, and S. aureus with minimum inhibitory concentration (MIC) values of 10, 10, and 100 μg/mL, respectively. Thiolutin (3) showed antibacterial activities against E. coli, BCG, M. tuberculosis, and S. aureus with MIC values of 6.25, 0.3125, 0.625, and 3.125 μg/mL, respectively.Entities:
Keywords: M. tuberculosis; antibacterial; marine-derived Streptomyces; thiolopyrrolone
Mesh:
Substances:
Year: 2022 PMID: 35323513 PMCID: PMC8953990 DOI: 10.3390/md20030214
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of 1–3.
1H (500 MHz) and 13C NMR (125 MHz) data of 1–3 (DMSO-d6).
| Position | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| 3/3′/3″ | 111.9/112.5/112.8 | 6.58/6.36/6.54, s | 109.6 | 7.56, s | 111.0 | 7.34, s |
| 3a/3a′/3a″ | 137.1/131.9/133.8 | 145.5 | 136.0 | |||
| 5/5′/5″ | 164.0/163.7/163.8 | 164.3 | 166.1 | |||
| 6/6′/6″ | 130.7/129.8/132.7 | 114.1 | 114.8 | |||
| 6a/6a′/6a″ | 124.6/124.6/126.4 | 123.1 | 132.4 | |||
| 8/8′/8″ | 168.4/168.3/167.9 | 170.5 | 168.8 | |||
| 9/9′/9″ | 22.9/22.8/22.8 | 2.07/2.06/2.07, s | 22.6 | 2.10, s | 22.4 | 2.02, s |
| 10/10′/10″ | 29.9/29.2/29.2 | 3.19/3.47/3.40, s | 27.9 | 3.10, s | 27.5 | 3.25, s |
| 7/7′/7″-NH | 10.27/10.21/10.17, s | - | 9.99, s | |||
Figure 2Key HMBC (arrows) correlations in 1 and 2.
Figure 3Four possible structures of 2 for calculating 13C NMR data in DMSO-d6.
Figure 4Calculated UV spectra for 2a–2d and UV spectrum for compound 2.
Comparison of calculated (TMS as a reference standard) and experimental 13C data for 2.
| Position | 2a | 2b1 | 2b2 | 2c | 2d | 2 |
|---|---|---|---|---|---|---|
| 3 | 115.2 | 110.2 | 111.8 | 107.4 | 103.9 | 109.6 |
| 3a | 129.4 | 147.5 | 140.2 | 121.2 | 140.2 | 145.5 |
| 5 | 162.1 | 160.5 | 159.0 | 159.6 | 159.2 | 164.3 |
| 6 | 112.9 | 130.4 | 127.9 | 131.1 | 121.1 | 114.1 |
| 6a | 138.1 | 135.9 | 131.3 | 124.5 | 129.5 | 123.1 |
| 8 | 167.3 | 164.1 | 163.5 | 163.4 | 163.9 | 170.5 |
| 9 | 21.3 | 23.1 | 22.8 | 23.0 | 22.6 | 22.6 |
| 10 | 27.6 | 27.4 | 26.8 | 26.4 | 27.3 | 27.9 |
|
| 0.9723 | 0.9776 | 0.9812 | 0.9534 | 0.9898 | |
| MAE | 5.6 | 5.4 | 5.4 | 7.3 | 4.6 | |
| MaxErr | 16.1 | 16.3 | 13.8 | 24.3 | 7.0 |
Antibacterial activities of compounds 1–3 (MIC, μg/mL).
| Number |
|
| BCG |
|
|
|---|---|---|---|---|---|
| 1 | >200 | 100 | 10 | 10 | >100 |
| 2 | >200 | 50 | - | - | >200 |
| 3 | >200 | 3.125 | 0.3125 | 0.625 | 6.25 |
| Control | 1 a | 1 b | 0.05 c | 0.025 c | 1 d |
a Rapamycin, b vancomycin, c isoniazid, d ciprofloxacin.